Participants 57 153 5
standard treatment in acute moderate to severe asthma in children between 5 and 15 years of age:
Participants 295 347 3
standard therapy in acute moderate to severe asthma.
Participants 397 479 4
Setting Emergency room/outpatient paediatric services of a tertiary care hospital.
Participants 489 677 7
Children aged 5-15 years (without prior use of montelukast) with acute moderate to severe asthma exacerbation, as defined using Modified Pulmonary Index Score (MPIS) > or =9, were enrolled
Participants 1069 1158 5
117 children (60 in montelukast group and 57 in placebo group) were enrolled in the study
Participants 1691 1736 3
children with acute moderate to severe asthma
